IT HAS BEEN A WHILE since a laboratory company has successfully completed an initial public offering (IPO). Thus, it is notable that LipoScience Inc., of Raleigh, North Carolina, recently accomplished that feat.
On January 24, 2013, Liposcience closed its IPO and raised $44.9 million. It now trades on NASDAQ under the stock symbol LPDX. The company